PHARMAMAR HA OPTADO POR LA RETIRADA DE LA SOLICITUD DE AUTORIZACIÓN DE COMERCIALIZACIÓN DE APLIDIN ( PLITIDEPSIN ) ... WITHDRAWAL OF APPLICATIÓN FOR THE MARKETING AUTHORISATION OF APLIDIN ( PLITIDEPSIN ) JULY 23 , 2025 .
Trabectedin (Yondelis) Pharma Mar S.A. 11 August 2008 Full submission For the treatment of patients with advanced soft tissue sarcoma (STS) after failure of anthracyclines and ifosfamide or who are unsuited to receive these agents .